The mechanism we put in through an emergency measure only addressed imports, so it wasn't the full regulation of products. There was a driving need to have supply come in. We wanted to make sure it was a safe supply, though, so we said that it had to be approved by a list of countries, again predominantly the United States.
There were also labelling requirements, but it really wasn't meant to pull out a full scheme for appraising products.
This is tailored, I would say. It's different from the current drug regime, but it's tailored for these products. That's the advance.... It's not less, but it's focused on the types of products.